Madrigal Pharmaceuticals announces additions to leadership team

Madrigal Pharmaceuticals (MDGL) announced three new members of its leadership team: Mark Barrett joins Madrigal as Chief Business Officer, Clint Wallace joins as Chief Human Resources Officer and Tina Ventura joins as Chief Investor Relations Officer. Mark Barrett brings more than 25 years of biopharmaceutical leadership and industry experience to Madrigal. He was most recently co-founder, Director, and CEO of Lassen Therapeutics, a biotechnology company focused on discovery and development of novel antibody therapeutics in immunological diseases and cancer. Clint Wallace joins Madrigal from Kenvue (KVUE), where he served as Senior Vice President Human Resources, Global Functions and Organizations and was responsible for organizational design and talent succession strategy. Tina Ventura brings nearly 25 years of experience in global health care investor relations and communications to Madrigal. Before joining Madrigal, she was Chief Investor Relations Officer at Horizon Therapeutics.